Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7d9efad87e0fb61ac65777be53aa204 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
filingDate |
2016-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_493ddd4b402110ec18a5c3243ee20ac0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa40448a142383c67abcaa5b063f4831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d674bba2453fa9a01263a7e4f08bccc |
publicationDate |
2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2702356-C2 |
titleOfInvention |
Transcutaneous suction composition |
abstract |
FIELD: medicine.SUBSTANCE: invention relates to a non-aqueous composition for enhancing transcutaneous suction of tizanidine or tizanidine hydrochloride, a matrix-type patch comprising such a non-aqueous composition dispersed in an adhesive layer, as well as to an agent for transcutaneous suction of tizanidine or tizanidine hydrochloride. Non-aqueous composition for enhancing transcutaneous suction of tizanidine or tizanidine hydrochloride contains tizanidine or tizanidine hydrochloride and sorbic acid and/or its salt with a metal. Concentration of sorbic acid and/or its salt with metal is 0.5–2.5 mol per mol of tizanidine or tizanidine hydrochloride.EFFECT: providing a non-aqueous composition for enhancing transcutaneous suction having an increased permeability of the basic drug.5 cl, 5 tbl, 6 ex |
priorityDate |
2015-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |